Alinia (nitazoxanide)
Recall D-0983-2015, part of FDA recall event 70914. See Romark Laboratories's company page.
Romark Laboratories, L.C. started this Class II drug recall on Apr 24, 2015 (voluntary: firm initiated); FDA lists it as terminated, terminated Oct 25, 2016.
- Classification: Class II
- Started: Apr 24, 2015
- Status: Terminated
Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity
- Product
- Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore, Maryland 21202 for Romark Laboratories 3000 Bayport Dr. Suite 200, Tampa, FL 33607
- Quantity
- 32,893 bottles
- Lots and codes
- Lot #: MTEW1721, MTCW21281, MTCW21291, Exp 09/2016; Lot #: MTEW5791, Exp 12/2016; Lot #: MTEW5801, Exp 01/2017.
- Distribution
- Nationwide
- Recalling firm
- Romark Laboratories, L.C., Tampa, FL, United States
- How the firm notified
- Letter
- FDA classified
- May 4, 2015
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports